Correction: Metabolic pathway for the universal fluorescent recognition of tumor cells

Ana Fernandez-Carrascal; Manuel Garcia-Algar; Moritz Nazarenus; Alicia Torres-Nuñez; Luca Guerrini; Neus Feliu; Wolfgang J. Parak; Eduardo Garcia-Rico; Ramon A. Alvarez-Puebla

doi:10.18632/oncotarget.27314

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: Metabolic pathway for the universal fluorescent recognition of tumor cells

PDF | How to cite

Oncotarget. 2019; 10:6643-6643. https://doi.org/10.18632/oncotarget.27314

Metrics: PDF 899 views | ?

Ana Fernandez-Carrascal^1,*, Manuel Garcia-Algar^1,*, Moritz Nazarenus¹, Alicia Torres-Nuñez¹, Luca Guerrini¹, Neus Feliu^2,3, Wolfgang J. Parak³, Eduardo Garcia- Rico⁴ and Ramon A. Alvarez-Puebla^1,5

¹ Department of Physical Chemistry and EMaS, Universitat Rovira i Virgili, Tarragona, Spain
² Karolinska Institutet, Stockholm, Sweden
³ Philipps-Universität Marburg, Fachbereich Physik, Marburg, Germany
⁴ Department of Medical Oncology, Hospital Universitario HM Torrelodones, Torrelodones, Madrid, Spain
⁵ ICREA, Barcelona, Spain
^* These authors have contributed equally to this work

Published: November 12, 2019

This article has been corrected: Due to errors in figure preparation, panels A and B of Figure 4 were accidentally duplicated. The corrected Figure 4 is shown below. The authors declare that these corrections do not change the results or conclusions of this paper.

Original article: Oncotarget. 2017; 8:76108–76115. DOI: https://doi.org/10.18632/oncotarget.18551.

Figure 4: (A–E) Flow cytometry plots of MCF-7 and PBMCs samples with cell ratios (A) 1:10, (B) 1:100, (C) 1:1000, (D) 1:10000 and (E) only PBMCs; upon incubation with 2-NBDG and CD45-APC for 30 minutes under hyperoxia conditions. (F–I) Distributions of fluorescence intensities for (F) 2-NBDG and (G) CD45-APC, in a sample with a 1:1000 MCF-7:PBMC ratio; and (H) 2-NBDG and (I) CD45-APC, in a sample of PBMC. Over 10⁶ single-cell events were collected for each experiment.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 27314

Publication Alerts

Corrections:

Correction: Metabolic pathway for the universal fluorescent recognition of tumor cells